Clinical trial
Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are…
NCT00143442 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143442 |
|---|---|
| Title | Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures |
| Official title | A 5-Week, Randomized, Double-Blind, Placebo-Controlled Multi-Center Study Of [S,S]-Reboxetine In Patients With Postherpetic Neuralgia (PHN), Who Are Gabapentin Treatment Failures. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain |
| Intervention type | Drug |
| Interventions | [S, S]-Reboxetine |
| Enrollment | 184 |
| Start date | Dec 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Sep 2, 2005 |
| Last update posted | Aug 8, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: